SynthesisPloS one2022

Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis.

Ning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.